IRIS
SCANDURRA, GIUSEPPA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.236
AS - Asia 736
EU - Europa 461
SA - Sud America 322
AF - Africa 22
OC - Oceania 1
Totale 2.778
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.200
SG - Singapore 303
BR - Brasile 260
HK - Hong Kong 193
IE - Irlanda 151
VN - Vietnam 112
IT - Italia 88
DE - Germania 62
GB - Regno Unito 37
FR - Francia 36
AR - Argentina 35
CN - Cina 34
TR - Turchia 22
CA - Canada 17
FI - Finlandia 16
MX - Messico 15
BD - Bangladesh 13
AT - Austria 12
EC - Ecuador 11
IN - India 11
ZA - Sudafrica 11
PL - Polonia 10
JP - Giappone 8
NL - Olanda 8
ID - Indonesia 7
MA - Marocco 7
UA - Ucraina 7
IQ - Iraq 6
RU - Federazione Russa 6
SE - Svezia 6
CZ - Repubblica Ceca 5
SA - Arabia Saudita 5
ES - Italia 4
KG - Kirghizistan 4
BO - Bolivia 3
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
PY - Paraguay 3
AL - Albania 2
LV - Lettonia 2
NP - Nepal 2
PE - Perù 2
PK - Pakistan 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BE - Belgio 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GR - Grecia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RO - Romania 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.778
Salva come PNG Salva come JPEG
Città #
Dallas 845
Hong Kong 193
Dublin 151
Singapore 150
The Dalles 57
Boardman 51
Ho Chi Minh City 51
Santa Clara 27
São Paulo 24
Ashburn 22
Hanoi 21
Los Angeles 20
Munich 20
Assago 16
Istanbul 16
London 15
Frankfurt am Main 14
Beijing 13
Milan 13
Helsinki 12
Rio de Janeiro 12
Palermo 11
Mexico City 10
Warsaw 10
Atlanta 8
New York 8
Belo Horizonte 7
Campinas 6
Chennai 6
Düsseldorf 6
Fortaleza 6
Misilmeri 6
Stockholm 6
Tokyo 6
Agrigento 5
Chicago 5
Haiphong 5
Portsmouth 5
Quito 5
San Francisco 5
Brasília 4
Brno 4
Brooklyn 4
Buenos Aires 4
Catania 4
Charlotte 4
Cologne 4
Curitiba 4
Jeddah 4
Johannesburg 4
Lauterbourg 4
Montreal 4
Nuremberg 4
Salvador 4
Seattle 4
Ankara 3
Baghdad 3
Bishkek 3
Biên Hòa 3
Can Tho 3
Cape Town 3
Colombo 3
Da Nang 3
Dhaka 3
Guayaquil 3
Joinville 3
Manchester 3
Naples 3
Phoenix 3
Porto Alegre 3
San Jose 3
Secaucus 3
Toronto 3
Três Lagoas 3
Turku 3
Varallo Pombia 3
Zurich 3
Amsterdam 2
Angra dos Reis 2
Aparecida de Goiânia 2
Aracaju 2
Asunción 2
Athens 2
Augusta 2
Bangkok 2
Boston 2
Cabo Frio 2
Cabo de Santo Agostinho 2
Campo Grande 2
Catanduva 2
Caxias do Sul 2
Council Bluffs 2
Criciúma 2
Duque de Caxias 2
Durban 2
El Jadida 2
Embu das Artes 2
Erbil 2
Guarujá 2
Guarulhos 2
Totale 2.041
Salva come PNG Salva come JPEG
Nome #
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 215
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 82
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer 73
Efficacy and safety of neoadjuvant paclitaxel, ifosfamide, and cisplatin (TIP) chemotherapy in locally advanced squamous cell cervical carcinoma followed by radical surgery: A single institution experience 72
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer 67
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 67
A Survey on the Prescribing Orientation Towards Complementary Therapies Among Oncologists in Italy: Symptoms and Unmet Patient Needs 67
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 66
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 65
Brain Metastasis in Endometrial Cancer: A Systematic Review 59
Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma 56
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy 49
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 49
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer 48
Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 48
Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study 47
De-escalation of complexity in oncoplastic breast surgery: Case series from a specialized breast center 45
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay 44
Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report 43
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 43
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 43
Appropriate Management of Cutaneous Adverse Events Maximizes Compliance with Sorafenib Treatment: A Single-Center Experience 42
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial? 42
Risk-reducing mastectomy in healthy women with BRCA mutation: a narrative review 42
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial 41
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 41
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review 41
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 40
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 39
Syringoid eccrine carcinoma of the vulva: differential diagnosis, treatment, and follow-up 39
Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy 39
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 39
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status 38
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity 38
The group's waiting room: groups of self-help in oncology 38
Synergistic Immune-Mediated Anti-tumour Effect of Dostarlimab and Radiotherapy in the Management of MSI-H/dMMR Endometrial Cancer: A Case Report 37
Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy 37
Correction: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial 36
The long survival in oncology: which QoL? Finding study in more than five years after the end of treatment 36
Real-World Analysis of HRD Assay Variability in High-Grade Serous Ovarian Cancer: Impacts of BRCA1/2 Mutation Subtypes on HRD Assessment 36
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 36
Trabectedin maintenance therapy after liposomal doxorubicin plus trabectedin combination in patients with relapsed ovarian cancer: the randomized, phase II TRAMANT study 35
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 35
Phase II Study of the Effectiveness of the Germinated Wheat-derived Rigenase Plus Polyhexanide in the Prophylaxis for Hypofractionated Radiation-induced Acute Skin Toxicity in Breast Cancer 35
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial 34
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study 31
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 30
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 29
Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrence ovarian cancer ( ROC) patients with BRCA 1/2 mutation. A monoistitutional experience 29
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer 28
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes 28
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 27
Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications 27
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma 26
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study 26
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society 26
Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial 25
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention 25
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study. 23
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort 23
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 23
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial 22
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel 21
Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance 20
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysis 20
Unveiling the Intricate Dance: How Cancer Orchestrates Muscle Wasting and Sarcopenia 20
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice 19
Multidisciplinary team for elucidation of any new mutation and how this approach can be useful to individualize any genetic result: the case of BRCA2 c.631G>A/c.7008-2A>T genotype 16
Exploratory Analysis of Dunning–Kruger Effect Among Oncologists Managing Prostatic Adenocarcinoma Candidates for Radionuclide Therapy 15
The importance of planning a correct therapeutic strategy in patients with recurrent ovarian cancer. 15
Breast-Conserving Surgery in BRCA Mutation Carriers: A Paradigm Shift Toward Individualized, Multidisciplinary Care 14
Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen 13
Totale 2.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.179
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 0 0 0 0 1 0
2023/2024213 1 2 13 10 24 16 34 21 14 18 26 34
2024/20251.049 40 17 30 8 61 131 110 100 127 153 149 123
2025/20261.622 186 519 574 269 74 0 0 0 0 0 0 0
Totale 2.885